• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析相关性腹膜炎的治疗:药代动力学原理

Treatment of peritonitis in APD: pharmacokinetic principles.

作者信息

Manley Harold J, Bailie George R

机构信息

University of Missouri - Kansas City, School of Pharmacy, Kansas City, Missouri 64108, USA.

出版信息

Semin Dial. 2002 Nov-Dec;15(6):418-21. doi: 10.1046/j.1525-139x.2002.00103.x.

DOI:10.1046/j.1525-139x.2002.00103.x
PMID:12437537
Abstract

Clinicians treating peritoneal dialysis (PD)-associated peritonitis should be aware that continuous ambulatory PD (CAPD) and automated PD (APD) have different effects on the pharmacokinetics of antibiotics. Results from various APD and comparative CAPD pharmacokinetic studies are reviewed. In APD patients, antibiotic half-lives were shorter during the cycler exchanges. Antibiotic peritoneal clearance was greater in patients treated with APD than those treated with CAPD regimens. Antibiotic clearance depends upon residual renal function and dialysate flow rate. To ensure that maximal antibiotic bioavailability occurs with intermittent intraperitoneal (IP) dosing, it is recommended that the antibiotic-containing dialysate must dwell at least 4 hours to ensure an adequate antibiotic depot in the body. Knowledge of antibiotic disposition in PD patients will assist clinicians in appropriate IP antibiotic dose selection and prevention of dose-related adverse effects.

摘要

治疗腹膜透析(PD)相关腹膜炎的临床医生应意识到,持续非卧床腹膜透析(CAPD)和自动化腹膜透析(APD)对抗生素的药代动力学有不同影响。本文综述了各种APD和CAPD药代动力学对比研究的结果。在APD患者中,循环器交换期间抗生素半衰期较短。接受APD治疗的患者抗生素腹膜清除率高于接受CAPD方案治疗的患者。抗生素清除率取决于残余肾功能和透析液流速。为确保间歇性腹腔内(IP)给药时抗生素达到最大生物利用度,建议含抗生素的透析液必须留存至少4小时,以确保体内有足够的抗生素储备。了解PD患者体内抗生素的处置情况将有助于临床医生合理选择IP抗生素剂量并预防剂量相关的不良反应。

相似文献

1
Treatment of peritonitis in APD: pharmacokinetic principles.腹膜透析相关性腹膜炎的治疗:药代动力学原理
Semin Dial. 2002 Nov-Dec;15(6):418-21. doi: 10.1046/j.1525-139x.2002.00103.x.
2
Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.接受腹膜透析的儿童腹腔内给药后万古霉素的处置情况。
Perit Dial Int. 2007 Jan-Feb;27(1):79-85.
3
Pharmacokinetics of culture-directed antibiotics for the treatment of peritonitis in automated peritoneal dialysis: A systematic narrative review.用于治疗自动腹膜透析中腹膜炎的培养导向性抗生素的药代动力学:一项系统性叙述性综述。
Perit Dial Int. 2021 May;41(3):261-272. doi: 10.1177/0896860821990528. Epub 2021 Feb 9.
4
Peritonitis and antibiotic therapy in patients on cycler peritoneal dialysis--an update.循环式腹膜透析患者的腹膜炎与抗生素治疗——最新进展
Adv Perit Dial. 2000;16:229-32.
5
Practice variations in antibiotic administration for the management of peritonitis in patients on automated peritoneal dialysis in Australia and New Zealand.在澳大利亚和新西兰,接受自动化腹膜透析治疗的腹膜炎患者的抗生素管理中,抗生素给药实践存在差异。
Perit Dial Int. 2022 Nov;42(6):647-651. doi: 10.1177/08968608211069231. Epub 2022 Jan 12.
6
Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.腹膜透析患者中短驻留周期腹腔内注射头孢唑林加头孢他啶
Perit Dial Int. 2017 Mar-Apr;37(2):218-224. doi: 10.3747/pdi.2015.00300. Epub 2016 Oct 13.
7
Review of Antibiotic Dosing with Peritonitis in APD.APD 中腹膜炎的抗生素剂量调整综述。
Perit Dial Int. 2019 Jul-Aug;39(4):299-305. doi: 10.3747/pdi.2018.00209.
8
Continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: are there differences in outcome?持续非卧床腹膜透析与自动化腹膜透析:结局有差异吗?
Contrib Nephrol. 2009;163:292-299. doi: 10.1159/000223813. Epub 2009 Jun 3.
9
Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.接受自动化腹膜透析治疗的患者间歇性静脉注射头孢唑林和妥布霉素的药代动力学
J Am Soc Nephrol. 2000 Jul;11(7):1310-1316. doi: 10.1681/ASN.V1171310.
10
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.万古霉素在腹膜透析中的应用:治疗中的临床药理学考虑。
Perit Dial Int. 2020 Jul;40(4):384-393. doi: 10.1177/0896860819889774. Epub 2020 Feb 17.

引用本文的文献

1
Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.头孢他啶和头孢唑林治疗持续性非卧床腹膜透析相关性腹膜炎的药代动力学分析。
Ren Fail. 2023;45(2):2285873. doi: 10.1080/0886022X.2023.2285873. Epub 2023 Dec 4.
2
Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis.奥司他韦在接受自动腹膜透析治疗的终末期肾病患者中的药代动力学及安全性
Br J Clin Pharmacol. 2015 Apr;79(4):624-35. doi: 10.1111/bcp.12526.
3
Treatment for peritoneal dialysis-associated peritonitis.
腹膜透析相关性腹膜炎的治疗
Cochrane Database Syst Rev. 2014 Apr 26;2014(4):CD005284. doi: 10.1002/14651858.CD005284.pub3.
4
Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.小儿腹膜透析患者导管相关感染和腹膜炎预防与治疗的共识指南:2012年更新版
Perit Dial Int. 2012 Jun;32 Suppl 2(Suppl 2):S32-86. doi: 10.3747/pdi.2011.00091.
5
Treatment and outcome of CPD-associated peritonitis.持续性非卧床腹膜透析(CPD)相关腹膜炎的治疗与转归
Ann Clin Microbiol Antimicrob. 2006 Apr 6;5:6. doi: 10.1186/1476-0711-5-6.